Searched for
ALOK SONIG
- Buy Dr. Reddy's Laboratories, target Rs 2715.0 : Siddharth BhamreBuy Dr. Reddy's Laboratories Ltd. at a price target of Rs 2715.0 and a stop loss at Rs 2560.0 from entry point05 May, 2017, 11.23 AM IST
- Sell Dr. Reddy's Laboratories, target Rs 2577.0 : Deen Dayal InvestmentSell Dr. Reddy's Laboratories Ltd. at a price target of Rs 2577.0 and a stop loss at Rs 2650 from entry point27 Apr, 2017, 12.13 PM IST
Dr Reddy's joins hands with Gland Pharma to market 8 ANDAs in USDr Reddy's is developing its injectable business and recently launched Paricalcitol injection, a therapeutic equivalent generic version of ...26 Oct, 2016, 10.47 PM IST- Dr. Reddy’s buys eight ANDAs from Teva for $350 millionDr. Reddy’s said the acquisition of ANDAs is contingent on closing of the Teva generics transaction and approval by the US Federal Trade Co...11 Jun, 2016, 01.01 PM IST
- Dr Reddy's buys 6 OTC brands from US-based Ducere PharmaDr Reddy's will build upon the sales and marketing efforts for these brands and continue to focus on their expansion into existing and new ...25 May, 2016, 05.05 PM IST
- Dr Reddy's picks Alok Sonig to lead North America generics businessIn a top level reshuffle, drug major Dr Reddy's Laboratories appointed Alok Sonig as Executive Vice President & Head for its generics busin...27 Aug, 2015, 09.05 PM IST
- Dr Reddy's rejigs top deck as North America head quitsVora will be replaced by Alok Sonig, who is currently responsible for the Indian market and is a member of the management council at the co...27 Aug, 2015, 10.15 AM IST
- Dr Reddy’s Laboratories eyes in-licensing pacts with European, Japanese firms to spur domestic revenueChief Financial Officer Saumen Chakraborty confirmed the ongoing talks with global firms for in-licensing agreements, but refused to divulg...07 Aug, 2015, 04.00 AM IST
- Dr Reddy's to market three Amgen drugs in IndiaDr Reddy's Laboratories today said it has inked a pact with US-based biotechnology firm Amgen to market its three drugs.06 Aug, 2015, 12.59 PM IST
- AstraZeneca, Dr Reddy's ink diabetes drug distribution pactBoth Riax and Riax M are trademarks of the AstraZeneca group. Dr Reddy's Laboratories will be distributing the two drugs in India.29 May, 2015, 08.05 PM IST
- Dr Reddy's launches drug for stroke patientsHyderabad-based firm has partnered with Spain's Ferrer Internacional SA to make Somazina available in India, Dr Reddy's Laboratories Ltd sa...15 May, 2015, 08.39 PM IST
- Dr Reddy's Laboratories to buy UCB's Indian arm for Rs 800 croreUCB, listed on Euronext Brussels, has operations in nearly 40 countries with revenues of €3.3 billion (about Rs 22,275 crore) in 2014.02 Apr, 2015, 06.32 AM IST
- Dr Reddy’s agrees to buy UCB business in India for Rs 800 croreThe deal will help Dr Reddy's strengthen its presence in dermatology, pediatrics and respiratory products, the company said in a statement ...01 Apr, 2015, 01.41 PM IST
- NPPA order may not impact much, seeking legal advice: Dr Reddy'sDrug pricing regulator NPPA has fixed the price of 108 non-scheduled formulation packs of 50 anti-diabetes and cardiac medicines.16 Jul, 2014, 03.45 PM IST
- Dr Reddy's Laboratories expects 8-10 pc growth in India generics business this fiscalDRL expects its Indian generic market to grow by 8-10% in the current financial year despite challenges such as price erosion due to new dr...10 Jan, 2014, 09.46 PM IST
- Ranbaxy gets a reprieve in generic caseThe Delhi High Court has turned down a plea by US pharma major Bristol-Myers Squibb (BMS) to ban India’s Ranbaxy Laboratories from launchin...25 Mar, 2010, 01.07 AM IST
Load More- Buy Dr. Reddy's Laboratories, target Rs 2715.0 : Siddharth Bhamre
